Thesis in One Paragraph

The market prices SQM as a lithium recovery play. It isn't — or rather, that's only half the story, and the less interesting half. SQM's lithium business loads 1:1 on the Global X Lithium ETF (LIT) with zero idiosyncratic alpha. You can replicate that exposure for 42bps/year. What you CAN'T replicate is the iodine business: a geological monopoly producing 42% of consolidated gross profit at 54% margins from ore deposits that exist nowhere else on Earth. The market hasn't figured out how to price this because it doesn't fit in a lithium model. Meanwhile, the Chilean fiscal architecture — primarily the Corfo lease's progressive rate schedule (6.8% at low prices, 40% above $10,000/MT) stacked with mining royalties and corporate tax — creates a hump-shaped earnings curve. SQM has missed estimates in four consecutive quarters by an average of 21%. Above ≈$25/kg lithium, the government captures the marginal dollar. Below $15, margins are thin. The sweet spot for shareholders is narrow.

Business Overview

SQM operates five segments built on two Chilean geological resources: lithium brine at the Salar de Atacama and iodine-rich caliche ore in the Atacama Desert.

Revenue Mix (FY2025: $4,576M)

The company's structure shifted dramatically in December 2025 when the Nova Andino Litio JV with Codelco (Chilean state copper company) formally closed, extending Salar de Atacama operations from 2031 to 2060. Minority interest jumped from $37M to $2,363M. A $430M hybrid bond (32-year maturity, 4% UF-denominated) was simultaneously issued as permanent capital to match the JV horizon. Nine new regional subsidiaries were created in 2024-2025 across China, Japan, Belgium, Greece, Canada, and the US — a vertical integration push toward end-markets.

The two businesses that matter:

Lithium (50% of revenue, 45% of GP): 233kt produced in FY2025 from Nova Andino at ≈$9.17/kg average realized price — bottom quartile of the global cost curve. Solar evaporation does the energy-intensive work. Mt. Holland JV with Wesfarmers (50/50) adds spodumene capacity, though the Kwinana hydroxide refinery has struggled. Management guides +10% volume growth in 2026 with 80% already contracted and Q1 pricing "significantly higher" than Q4.

Iodine (23% of revenue, 42% of GP): 14.5kt sold in FY2025 at ≈$72/kg — record pricing. SQM controls ≈37% of global iodine supply from caliche ore deposits that exist only in Chile's Atacama Desert. There is no other ore-based iodine source on Earth. Primary end-market is X-ray contrast media (≈37% of demand), where GE HealthCare — the dominant buyer — reports 12.7% organic growth and is investing $138M to expand capacity. GEHC's CEO says no new competitors are emerging and supply is "top of mind for customers." A seawater pipeline completing Q2 2026 expands SQM's iodine capacity to ≈17kt.

Financial Profile

The Four-Year Story

Revenue collapsed from $10.7B (2022) to $4.6B (2025) as lithium prices fell from ≈$70/kg to ≈$9/kg. The entire P&L trajectory is lithium price. Strip out lithium and the rest of the business grew: iodine revenue up 38% ($754M to $1,043M), SPN stable.

*FY2024 has two versions. The 20-F (filed April 2025) shows $685M NI with 29% tax. The Q4 2025 6-K (filed March 2026) restated FY2024 to show a $(404M) net loss with $1,372M tax — a $1.1B swing driven by retroactive recognition of the SII mining tax dispute (courts ruled SQM owed specific mining taxes on lithium for fiscal years 2011-2022 that the company had argued did not apply). This restatement is material: the Chilean government retroactively reclassified lithium mining to subject it to a tax SQM believed it was exempt from. It reinforces the sovereign risk theme.

The Chilean fiscal architecture — how it actually works:

SQM's lithium earnings face four stacking fiscal layers, each sourced from the 20-F and audited IFRS financials:

Layer 1: Corfo lease (progressive, 20-F disclosed rate table):

The LiOH rate table is slightly more favorable — the 40% threshold kicks in at $12,000/MT ($12/kg) instead of $10,000/MT. As SQM expands hydroxide capacity (40kt to 100kt), more revenue shifts to the higher-threshold table. (Source: 20-F lines 7072-7082.)

At FY2025's ≈$9.17/kg ($9,170/MT), the blended Corfo rate was approximately 21-24% (confirmed by 20-F: "Corfo accounted for approximately 24% of this business line's cost of sales," line 3413). At $20/kg, it's 40% on everything above $10/kg — the majority of revenue. At FY2022's peak ≈$70/kg, the Corfo lease alone consumed 40% of nearly all lithium revenue. This single rate table is the primary source of the non-linear earnings profile.

Layer 2: IEAM (specific mining tax): 5.24% on lithium mining activity (20-F disclosed, fixed rate).

Layer 3: Corporate income tax: 27% (Chilean statutory rate).

Layer 4: Codelco minority: 33,500t / total LCE × Adjusted Net Income (JV agreement, 6-K disclosed).

These layers stack. The Corfo lease is the dominant non-linear element — it jumps from 25% to 40% at the $10/kg threshold, creating a cliff in shareholder economics exactly where recovery begins.

FY2023's 66.9% effective tax rate included a ≈$1.1B catch-up charge for the SII mining tax dispute (retroactive IEAM charges for 2011-2022), so it overstates the steady-state effective rate at peak prices. A more conservative estimate of steady-state effective government take: ≈30-35% at $10/kg, ≈45-50% at $25/kg, ≈55-60% at $50/kg. These are proprietary estimates derived from the Corfo rate table, IEAM rate, and corporate tax rate — not disclosed as a single figure in any filing.

Q4 2025 showed inflection: Gross margin hit 33.9% (vs 27.6% in Q3), driven by lithium price recovery and record iodine pricing. If this trajectory holds, FY2026 margins should expand materially. But the tax architecture means margin expansion flows to shareholders at a decreasing rate.

Balance Sheet

Leveraged up to fund capex ($900M-1.1B/yr), the Codelco JV ($480M), and Mt. Holland. Debt is serviceable but elevated. Free cash flow was approximately $90M in FY2025 — essentially break-even after capex. SQM is investing aggressively through the trough (lithium hydroxide expansion 40kt to 100kt, seawater pipeline, Salar Futuro permitting), which is the right strategy for the lowest-cost producer but leaves no capital return cushion.

Capital Return

Chilean law mandates 30% minimum dividend payout but SQM cannot legally repurchase shares. Dividends were massively pro-cyclical: $2.2B in 2022, $1.5B in 2023, $67M in 2024. Capital returned at peak prices, retained at trough. This is the opposite of countercyclical capital allocation, though partly driven by statutory requirements.

Competitive Position

Lithium: Cost Moat, Not Monopoly

SQM holds ≈17% global lithium market share at bottom-quartile cost. Albemarle operates in the same Salar de Atacama with equivalent geology. ALB's CEO confirms Atacama is "one of the lowest cost sources in the world" — Kemerton's idling proves Western hard rock hydroxide is uneconomic at current prices. ALB estimates 25%+ of global production is below breakeven.

The moat is real but shared. SQM and ALB together control the world's best lithium resource. The competitive question isn't whether Atacama brine is superior (it is, by $4-5/kg vs hard rock), but whether new supply from Rio Tinto/Arcadium (targeting 200kt by 2028), Greenbushes CGP3, and potentially restarted Chinese lepidolite will outpace demand growth.

Both ALB and Rio Tinto confirm energy storage (ESS) demand grew 80%+ in 2025 and is "surprising to the upside." Lithium demand grew ≈30% in 2025 to ≈1.6M tonnes. 2026 outlook: 15-40% growth (ALB's wide range reflects genuine uncertainty).

Iodine: Geological Fortress

This is where defensibility is absolute. Caliche ore — the only economic ore-based iodine source — exists exclusively in Chile's Atacama Desert. SQM (≈37% share) and a handful of Chilean producers (Cosayach, ACF Minera) control 65% of global supply. The remainder comes from Japanese natural gas brine (≈30%) and small recycled/byproduct streams.

No new iodine capacity has come online in 8 years. GEHC is investing $138M to expand contrast media manufacturing — they wouldn't do this if they saw supply alternatives. GEHC's CEO explicitly stated no new competitors are "developing at this point in time." The one early-stage threat is Select Water Solutions (WTTR), which mentioned iodine extraction from produced water on their Q4 2025 call — but this is pilot-scale and years from commercial viability.

SQM's iodine pricing has risen from ≈$52/kg (FY2022) to >$73.5/kg (Q4 2025) — a 41% increase while lithium prices collapsed 87%. Iodine pricing power is demonstrated, persistent, and structurally defensible.

Iodine bear cases (for balance): GEHC's 12.7% organic growth is blended across iodinated contrast (CT/X-ray — SQM's market) and gadolinium-based contrast (MRI — different supply chain); the iodine-specific attribution is unclear. Customer concentration is severe: top 2 customers account for 33% of iodine sales, top 10 for 77%. Healthcare cost pressure could limit pricing power even without supply alternatives. And while WTTR's produced-water iodine extraction is early-stage, any scalable non-Chilean source would erode the geological premium. A dominant incumbent (GEHC CEO) saying "no new competitors" should be discounted — they have incentive to downplay threats to protect their own valuation.

What's Defensible vs Commoditized

Management & Governance

Board: Controlled by Pampa Group (25.8%) and Tianqi Lithium (22.2%), who together hold 94.2% of Series A voting shares and elect 7 of 8 directors. ADR holders (≈17% economic interest) elect one director. Tianqi — a direct lithium competitor — has two board seats. SQM's own 20-F states the antitrust framework with Tianqi "could not effectively resolve the risks" of competitor access to sensitive information.

Management: CEO Ricardo Ramos has been at SQM since 1989 (CFO 1994-2018, CEO 2019-present). Deep institutional knowledge. A June 2024 reorganization created three division CEOs — likely succession planning. No outside perspective at the top.

Insider ownership: Effectively zero. CFO owns 800 shares ($58K). Most directors and officers own nothing. Compensation is cash profit-sharing (0.06-0.12% of net income per director), not equity. Individual executive compensation is not disclosed — standard Chilean practice but a governance gap for ADR investors.

Tianqi dynamics: On January 26, 2026, Chile's Supreme Court definitively rejected Tianqi's appeal against the Codelco JV. On February 4, Tianqi announced it would sell 1.25% of SQM (≈$206M). Initial filings had authorized selling the entire 22% stake within one year — that's ≈$4.6B of potential supply at current prices. At the initial tranche pace (1.25% per sale), full liquidation would require ≈17 tranches. SQM's 3-month average daily volume is ≈$90M — sustained selling of this magnitude would create persistent technical pressure for 6-18 months. Tianqi's financial condition has deteriorated (7.9B yuan net loss in 2024, though recovering in 2025). Governance frustration is the primary driver; financial pressure is secondary. The qualitative offset: Tianqi's exit would remove the structural conflict of a competitor on the board, potentially simplifying governance. But this is a qualitative benefit against a quantifiable headwind.

Overall governance: below average for a $20B company. Operational excellence (lowest-cost lithium, dominant iodine) compensates for structural governance weakness.

Factor Profile

SQM's returns are dominated by the lithium factor. This isn't opinion — it's regression output.

Variance Decomposition (1-year, daily returns)

Without the lithium factor, SQM looks 75% idiosyncratic with 44% alpha. Include LIT and the truth emerges: 43% idio, zero alpha. The "alpha" was lithium beta in disguise. This is the textbook Paleologo warning — wrong factor model produces fake alpha.

SQM's 1-year return (+74.8%) nearly perfectly matches LIT (+77.1%). Albemarle outperformed both at +119.6%, reflecting higher operational leverage and aggressive cost restructuring. SQM has been the inferior vehicle for lithium exposure over the past year.

Recent divergence (120-day window): Idiosyncratic variance rose to 52% with 47.3% annualized alpha. This coincides with the Codelco JV completion (Dec 2025), Q4 margin inflection, and iodine price surge — all company-specific events. The 1-year regression includes 130+ days of pre-JV data where SQM was a pure lithium proxy. Our view: the 1-year regression is the better baseline for sizing (you're still primarily buying lithium beta), but the 120-day divergence is evidence that the iodine/JV thesis is beginning to show up in returns. If idiosyncratic variance sustains above 50% for another quarter, it would signal a structural shift in SQM's factor profile worth re-evaluating. For now, treat 43% idio as the working number and the 52% as a thesis to monitor, not to trade on.

Negative market beta (-0.20 vs SPY) is notable. SQM trades inversely with the US equity market — a function of Chilean/EM discount, dollar dynamics, and commodity counter-cyclicality. This makes SQM a potential portfolio diversifier, but it also means it underperforms in risk-on environments.

Bottom line: This is primarily a factor bet. To justify owning SQM over LIT, you need conviction in one or more company-specific factors the ETF doesn't capture: iodine valuation, Codelco JV structure, or Chilean sovereign risk assessment.

Forward Expectations Gap

What $73 Requires

Forward P/E of 13.45x implies NTM EPS of $5.44 — a 164% increase from FY2025's $2.06. Working backwards through SQM's cost structure and tax layers:

$73 requires full-year average lithium at ≈$30-33/kg. ALB reports January 2026 average pricing was ≈$20/kg. China CIF spot is $10-12/kg. For the full year to average $30+, prices need to nearly double from the January inflection and sustain. Possible in a supply crunch but not base case.

The Hump-Shaped Earnings Curve

SQM's EPS sensitivity to lithium price is not linear. It is hump-shaped: sensitivity increases from $10 to $20/kg as margins expand, then decreases above $20-25/kg as the Corfo lease's 40% marginal rate and other fiscal layers capture the upside. This is driven by the Corfo rate table (see Financial Profile section) — the jump from 25% to 40% at the $10,000/MT threshold creates a cliff in shareholder economics.

Proprietary EPS sensitivity estimates (model assumptions: 256kt lithium volume, iodine $75/kg at 16kt, SPN/other $1,400M, SG&A 7-8% of revenue, interest $250M, D&A $450M, Codelco minority at 33,500t/256kt = 13.1%):

The $15-25/kg range is the sweet spot for SQM shareholders. Below $15, margins are thin. Above $25, the Chilean government's share escalates. This is structurally different from ALB, which operates under a more linear US tax regime. No external model validation has been performed — these estimates should be treated as directional, not precise.

If Chinese lepidolite restarts (bear scenario): ALB's Eric Norris hedged: "Expect possible some come back on in coming year." If 30-50kt restarts in H2 2026, full-year average lithium could settle at $12-15/kg instead of $15-22/kg, delivering $2.06-$2.42 EPS — essentially no improvement from FY2025. This scenario is not priced into $73.

Street vs Our Research: Five Disconnects

1. Chilean fiscal architecture (SYSTEMATIC ERROR): Street likely uses ≈30-35% blended effective tax rate. The Corfo lease alone takes 40% of lithium revenue above $10,000/MT, before IEAM (5.24%) and corporate tax (27%). Our proprietary estimate of effective government take: 30-35% at $10/kg, 45-50% at $25/kg. SQM missed four consecutive quarters by an average of 21% — consistent with fiscal under-modeling, though other factors (volume, FX, one-offs) may also contribute.

2. Iodine contribution (BULLISH DISCONNECT): Street models iodine as stable/secondary. Our counterparty research shows GEHC contrast media growing 12.7% organically, $138M capacity expansion, CEO seeing no new competitors. Iodine could surprise $0.30-0.50/share to upside vs consensus.

3. Kwinana execution (BEARISH DISCONNECT): SQM was diplomatic ("progressing through ramp-up phase"). Wesfarmers acknowledges intermittent odor issues extending the timeline. IGO's CEO was blunt: Kwinana "missed plans, expectations, promises on all fronts." Hydroxide contribution delayed to 2027+.

4. Codelco volume formula (BULLISH DISCONNECT): The fixed 33,500t formula — not a percentage — means Codelco's economic share decreases as SQM grows volumes: 14.4% at 233kt, 12.9% at 260kt, 8.4% at 400kt. Every incremental ton above 33,500 is 100% SQM. Street may model a fixed percentage.

5. Lithium price implied (OPTIMISTIC): Consensus NTM EPS of ≈$5.44 requires ≈$30-33/kg full-year average. Most likely outcome at $15-22/kg delivers $2.42-$3.80. The stock is priced for a stronger lithium recovery than current spot supports.

Sum-of-Parts

Caveat: SQM does not report segment-level EBITDA or allocate assets to segments. All EBITDA figures below are proprietary estimates based on segment gross profit plus estimated D&A allocation. These are directional, not audited.

At $73, SQM trades above SOTP top end on trough earnings. Defensible only at mid-cycle lithium ($20/kg+ sustained) and/or iodine at premium specialty chemical multiples (20x+). Not unreasonable for a cyclical recovery — but requires the recovery to happen AND the fiscal architecture to not eat the upside.

Key Risks

Sovereign / Regulatory

• Expropriation bill (Bulletin 10,638-08) names SQM specifically. Purpose: "enable the potential expropriation of our assets, or our lithium operations in general." Direct 20-F disclosure.
• State capture escalation. Codelco press statements estimate the Chilean state captures ≈70% of lithium operating margin (2025-2030), rising to ≈85% post-2031 when Codelco's JV share increases. These figures are NOT in SQM's own filings and should be treated as secondary-source estimates (credibility 0.70). However, they are directionally consistent with our bottom-up calculation from the Corfo rate table (40% above $10,000/MT) + IEAM (5.24%) + corporate tax (27%) + Codelco minority (≈13%), which produces ≈55-65% total government take at $20/kg.
• $1.1B SII tax dispute: The government retroactively reclassified lithium mining to subject it to the IEAM (specific mining tax) for fiscal years 2011-2022. Three of seven claims rejected at trial AND appeal. Trend running against SQM in courts. Provisioned but Supreme Court decisions pending. This is the clearest evidence of Chilean willingness to change the rules retroactively.
• Water Code amendment (2022): Water rights changed from perpetual to 30-year max. Atacama operations are water-dependent.
• Pension reform (Jan 2025): Employer contributions increasing from 1.5% to 8.5% of wages over 9 years. With 7,258 Chilean employees, adds $15-25M annual cost at full implementation.

Operational

• Kwinana refinery: "Missed plans, expectations, promises on all fronts" (IGO CEO). Odor fix due mid-2026. Full hydroxide production 2027 best case.
• Lithium price dependence: 54% of return variance explained by lithium factor. A sustained return below $10/kg would pressure margins despite low cost position.
• Capex intensity: 22-25% of revenue with thin FCF. Investing through trough is correct strategy but leaves no margin for error.

Governance

• Tianqi stock overhang: 22% holder authorized to sell. Initial 1.25% tranche is a test. 6-12 month technical pressure.
• Zero insider ownership. Management has no meaningful equity skin in the game. Meanwhile, key management compensation surged 63% YoY ($24M to $39.2M in 9-month periods) on only 6% headcount growth — significant retention/restructuring bonuses during the Codelco JV transition.
• Foreign private issuer limitations. No DEF 14A, no individual compensation disclosure, no Form 4 insider reporting. ADR holders have limited governance visibility and one board seat out of eight. SQM does not allocate assets or liabilities to segments — investors cannot assess return on capital by business line.

Competitive

• DLE technology: 20-F acknowledges direct lithium extraction could "significantly increase the supply of lithium from brine projects and reduce their cost of production." ALB's DLE pilot is operational. If DLE works at scale, Atacama's solar evaporation advantage narrows.
• New lithium supply: Rio Tinto targeting 200kt by 2028 ($1B/year investment). Greenbushes CGP3 ramping. Chinese lepidolite may restart if environmental restrictions ease.
• Iodine substitution: WTTR exploring iodine extraction from produced water. Very early stage (pilot, not commercial) but worth monitoring.

What to Watch

Near-term (0-6 months):

• Q1 2026 earnings (May 26): Does the margin inflection hold? What does "significantly higher" lithium pricing translate to in actual EPS? Does the street miss pattern continue?
• Iodine seawater pipeline completion (Q2 2026): Expands capacity to ≈17kt. Volume and pricing trajectory post-expansion.
• Tianqi stake sales: Pace and market impact. Does 1.25% tranche lead to accelerated selling?

Medium-term (6-18 months):

• Lithium price sustainability: Does $20/kg hold through H2 2026, or does it fade as new supply comes online (Greenbushes CGP3, Rio Tinto projects)?
• Kwinana refinery: Does the odor fix work? When does hydroxide production reach meaningful scale?
• Salar Futuro environmental approval (expected mid-2026): Opens next-generation Atacama resource.
• 120-day factor divergence: Is SQM developing genuine idiosyncratic alpha (iodine-driven), or does it revert to being a lithium ETF proxy?

Long-term (18+ months):

• Codelco JV economics post-2030: What percentage of lithium profits does SQM actually retain at scale? The 33,500t fixed formula is favorable now; how it evolves matters.
• Chilean political risk: Does the expropriation bill advance? Does the mining royalty get tightened if lithium booms?
• DLE technology: If ALB's DLE pilot scales successfully, does it change the cost curve structure for all brine producers?
• Iodine SOTP recognition: Does the market ever price iodine at specialty chemical multiples? What would catalyze a rerating — segment disclosure, spin-off, activist?

LR Signal: 0.80

Moderately bearish divergence from market pricing.

The market prices SQM for a lithium recovery that delivers $5.44 NTM EPS. Our analysis shows the Chilean fiscal architecture creates a hump-shaped earnings curve where ≈$3.50-4.50 is more likely at achievable lithium prices ($20-25/kg). The systematic quarterly miss pattern (-21% average over 4 quarters) is consistent with fiscal under-modeling, though we cannot decompose individual misses to prove causation. SOTP analysis places fair value at $43-67 on trough earnings, below current $73 — the stock trades above the top of its own SOTP range.

The partial offset is iodine undervaluation — a genuine mispricing the market hasn't addressed because it doesn't fit the lithium narrative. If iodine alone were valued at specialty chemical multiples (15-20x estimated EBITDA), it would represent $30-40/share of equity value. But this thesis lacks a near-term catalyst (no spin-off discussion, no separate segment disclosure, no activist involvement).

Net: the stock is moderately expensive for what it delivers. Bearish evidence (fiscal architecture, SOTP gap, Tianqi overhang, expropriation bill) is more numerous and more material to current price than bullish evidence (iodine fortress, Codelco volume formula). The bullish case requires either (a) sustained lithium above $25/kg, or (b) iodine rerating, or (c) both. What would raise the LR: lithium sustained above $20/kg for two consecutive quarters, iodine segment disclosure or spin-off discussion, expropriation bill dying in committee. What would lower it: Chinese lepidolite restart, Tianqi accelerating sales, mining royalty tightening, iodine pricing rollover.

Evidence